Neu–Laxova syndrome

From WikiMD's Wellnesspedia


Prab-R-Tumpati-MD.jpeg

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss and sleep centers



WikiMD Resources for Neu–Laxova syndrome
Articles
Most recent articles on Neu–Laxova syndrome

Most cited articles on Neu–Laxova syndrome Review articles on Neu–Laxova syndrome

Articles on Neu–Laxova syndrome in N Eng J Med, Lancet, BMJ

Media
Powerpoint slides on Neu–Laxova syndrome

Images of Neu–Laxova syndrome Photos of Neu–Laxova syndrome

Podcasts & MP3s on Neu–Laxova syndrome Videos on Neu–Laxova syndrome

Evidence Based Medicine
Cochrane Collaboration on Neu–Laxova syndrome

Bandolier on Neu–Laxova syndrome TRIP on Neu–Laxova syndrome

Clinical Trials
Ongoing Trials on Neu–Laxova syndrome at Clinical Trials.gov

Trial results on Neu–Laxova syndrome Clinical Trials on Neu–Laxova syndrome at Google

Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Neu–Laxova syndrome

NICE Guidance on Neu–Laxova syndrome NHS PRODIGY Guidance

FDA on Neu–Laxova syndrome CDC on Neu–Laxova syndrome

Books
Books on Neu–Laxova syndrome
News
Neu–Laxova syndrome in the news

Be alerted to news on Neu–Laxova syndrome News trends on Neu–Laxova syndrome

Commentary
Blogs on Neu–Laxova syndrome
Definitions
Definitions of Neu–Laxova syndrome
Patient Resources / Community
Patient resources on Neu–Laxova syndrome

Discussion groups on Neu–Laxova syndrome Patient Handouts on Neu–Laxova syndrome

Directions to Hospitals Treating Neu–Laxova syndrome Risk calculators and risk factors for Neu–Laxova syndrome

Healthcare Provider Resources
Symptoms of Neu–Laxova syndrome

Causes & Risk Factors for Neu–Laxova syndrome Diagnostic studies for Neu–Laxova syndrome

Treatment of Neu–Laxova syndrome

Continuing Medical Education (CME)
CME Programs on Neu–Laxova syndrome
International / other languages

syndrome en Espanol syndrome en Francais

Business
Neu–Laxova syndrome in the Marketplace

Patents on Neu–Laxova syndrome

Experimental / Informatics
List of terms related to Neu–Laxova syndrome


Neu–Laxova syndrome
Other namesNeu-Povysilová syndrome

Neu–Laxova syndrome (also known as Neu syndrome or Neu-Povysilová syndrome, abbreviated as NLS) is a rare autosomal recessive disorder characterized by severe intrauterine growth restriction and multiple congenital malformations. Neu–Laxova syndrome is a very severe disorder, leading to stillbirth or death shortly after birth. It was first described by Dr. Richard Neu in 1971[1] and Dr. Renata Laxova in 1972[2] as a lethal disorder in siblings with multiple malformations. Neu–Laxova syndrome is an extremely rare disorder with less than 100 cases reported in medical literature.

Signs and symptoms[edit | edit source]

Neu-Laxova syndrome presents with severe malformations leading to prenatal or neonatal death. Typically, NLS involves characteristic facial features, decreased fetal movements and skin abnormalities.[3] Fetuses or newborns with Neu–Laxova syndrome have typical facial characteristics which include proptosis (bulging eyes) with eyelid malformations, nose malformations, round and gaping mouth, micrognathia (small jaw) and low set or malformed ears. Additional facial malformations may be present, such as cleft lip or cleft palate. Limb malformations are common and involve the fingers (syndactyly), hands or feet. Additionally, edema and flexion deformities are often present. Other features of NLS are severe intrauterine growth restriction, skin abnormalities (ichthyosis and hyperkeratosis) and decreased movement. Malformations in the central nervous system are frequent and may include microcephaly, lissencephaly or microgyria, hypoplasia of the cerebellum and agenesis of the corpus callosum. Other malformations may also be present, such as neural tube defects.[citation needed]

Genetics[edit | edit source]

Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by homozygous or compound heterozygous mutations in one of three genes: PHGDH, PSAT1 and PSPH[4][5] These genes are involved in the serine biosynthesis pathway and are essential for cell proliferation. Mutations in all three genes had been previously identified as the cause of serine-deficiency syndromes. Although there is some clinical overlap between NLS and these neurometabolic disorders, the phenotype in other serine-deficiency disorders is milder.

Diagnosis[edit | edit source]

The diagnosis is usually based on clinical features present at birth. Ultrasound in the second trimester may show abnormalities associates with NLS, including polyhydramnios, intrauterine growth restriction, microcephaly, proptosis and decreased fetal motility.[citation needed]

Treatment[edit | edit source]

Serine and glycine supplementation has shown tentative benefits in those with related serine biosynthesis defects and milder forms of NLS[6]

Prognosis[edit | edit source]

The prognosis is poor; affected individuals are either stillborn or die shortly after birth. The longest survival reported in literature is of 134 days. This syndrome is transmitted as an autosomal recessive disorder and there is a risk for recurrence of 25% in future pregnancies.

References[edit | edit source]

External links[edit | edit source]

Classification
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD